SCHEMBL27255151

SCHEMBL27255151

CNSc1ccc2[nH]ccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.47
NR4A2 P43354 2/20 0.47
CYP2A6 P11509 2/20 0.47
F7 P08709 1/20 0.47
LTA4H P09960 1/20 0.47
F3 P13726 1/20 0.47
USP2 O75604 1/20 0.47
GAA P10253 1/20 0.47
ALOX15 P16050 1/20 0.47
RAD51 Q06609 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
IMPDH2 P12268 1/20 0.43
IMPDH1 P20839 1/20 0.43
FYN P06241 1/20 0.43
NPC1 O15118 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C19 P33261 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2942909 0.79 AHR (0.54) AHRNR4A2CYP2A6F7LTA4H
SCHEMBL27988235 0.74 F2 (0.50) AHRNR4A2CYP2A6F7LTA4H
SCHEMBL5134026 0.74 AHR (0.52) AHRNR4A2CYP2A6F7LTA4H
SCHEMBL31543700 0.73 AHR (0.52) AHRNR4A2CYP2A6F7LTA4H
SCHEMBL13230543 0.73 AHR (0.47) AHRNR4A2CYP2A6F7LTA4H
SCHEMBL2976878 0.72 MAOB (0.51) AHRNR4A2CYP2A6F7LTA4H
SCHEMBL19063316 0.72 NPC1 (0.51) AHRNR4A2CYP2A6F7LTA4H
SCHEMBL31543727 0.70 AHR (0.44) AHRNR4A2CYP2A6F7LTA4H
SCHEMBL2889663 0.69 NPC1 (0.56) AHRNR4A2CYP2A6F7LTA4H
SCHEMBL31543723 0.69 AHR (0.43) AHRNR4A2CYP2A6F7LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024080792-A1 NOVEL HETEROBICYCLIC COMPOUND FOR INHIBITING YAP-TEAD INTERACTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME HANMI PHARM. CO., LTD. (KR) 2024-04-18 WO disclosed